Tue. 6 Feb 2024, 7:01am ET
Benzinga
Earnings, News
Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.58) by 6.9 percent. This is a 10 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $48.30 million which beat the analyst consensus estimate of $45.92 million by 5.17 percent. This is a 32.88 percent increase over sales of $36.34 million the same period last year.